HLA-DOA
HLA class II histocompatibility antigen, DO alpha chain
Also known as: DOA_HUMAN, HLA-D0-alpha, HLA-DNA, HLA-DZA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06340
- Gene
- HLA-DOA
- Ensembl
- ENSG00000204252
- Chromosome
- 6
- Canonical length
- 250 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB. The heterodimer, HLA-DO, is found in lysosomes in B cells and regulates HLA-DM-mediated peptide loading on MHC class II molecules. In comparison with classical HLA class II molecules, this gene exhibits very little sequence variation, especially at the protein level. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
250 residues, UniProt reviewed canonical sequence.
>P06340|HLA-DOA
1 MALRAGLVLG FHTLMTLLSP QEAGATKADH MGSYGPAFYQ SYGASGQFTH EFDEEQLFSV
61 DLKKSEAVWR LPEFGDFARF DPQGGLAGIA AIKAHLDILV ERSNRSRAIN VPPRVTVLPK
121 SRVELGQPNI LICIVDNIFP PVINITWLRN GQTVTEGVAQ TSFYSQPDHL FRKFHYLPFV
181 PSAEDVYDCQ VEHWGLDAPL LRHWELQVPI PPPDAMETLV CALGLAIGLV GFLVGTVLII
241 MGTYVSSVPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-DOA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- spleen: 27 nTPM
- tonsil: 19 nTPM
- small intestine: 14 nTPM
- lymph node: 14 nTPM
- lung: 12 nTPM
- spinal cord: 8.9 nTPM
Single-cell type
- microglia: 20 nCPM
- b-cells: 6.5 nCPM
- cdc: 4.8 nCPM
- papillary tip epithelial cells: 4.6 nCPM
- renal collecting duct principal cells: 3.9 nCPM
- macrophages: 3.1 nCPM
Immune cell
- naive B-cell: 21 nTPM
- myeloid DC: 18 nTPM
- memory B-cell: 15 nTPM
- intermediate monocyte: 6 nTPM
- plasmacytoid DC: 5 nTPM
- non-classical monocyte: 4.7 nTPM
Brain region
- medulla oblongata: 4.6 nTPM
- pons: 3.1 nTPM
- hypothalamus: 3 nTPM
- white matter: 3 nTPM
- spinal cord: 2.5 nTPM
- midbrain: 2.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HLA-DOA.
Disease | ImmuneIEDB
Conditions an epitope on HLA-DOA was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- negative regulation of antigen processing and presentation of peptide antigen via MHC class II
- peptide antigen assembly with MHC class II protein complex
- positive regulation of immune response
- positive regulation of T cell activation
- regulation of T cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MHC class II, alpha chain, N-terminal
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- MHC class II, alpha/beta chain, N-terminal
- Immunoglobulin-like domain superfamily
- Major Histocompatibility Complex/Immunoglobulin
- Class II histocompatibility antigen, alpha domain
- Immunoglobulin C1-set domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-DOA as an antibody target. Whether an autoantibody or antibody against HLA-DOA could matter depends on whether native HLA-DOA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-DOA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HLA-DOA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...